Digitek Injury Lawsuit Filed In West Virginia
On June 23, 2008, a federal lawsuit was filed by an Ohioan against a West Virginia pharmaceutical company after he was given a dangerous level of Digitek, a heart medication. The plaintiff filed the suit against Mylan Pharmaceuticals in the U.S. District Court of the Southern District of West Virginia, Parkersburg Division.
According to the suit, there have been at least 11 complaints about the adverse side effects, including illnesses and injuries since 2006.
After taking the drug, the plaintiff learned that the drug contained twice the approved level of active ingredients. According to the suit, the defendants failed to notify the public of the dangers of the drug, which caused the plaintiff to suffer bodily injury and damages.
In April 2008, a nationwide recall was ordered for the heart-failure medication Digitek (digoxin) after an unknown number of pills thought to contain twice the dose of the drug’s active ingredient were given to patients. Approximately a dozen reports of deaths, illness, and injuries to patients taking the drug have been reported since the suspected double-doses were discovered.
Actavis Totowa LLC, a United States division of the international generic pharmaceutical company Actavis Group, manufactures Digitek. Mylan Pharmaceuticals, Inc. distributes the drug under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label.